Challenge the current pediatric blood cancer landscape
In the current era of targeted and immuno-oncology drugs being developed in adults, very few successful examples have been translated to childhood blood cancer treatment. Clear advances have occurred, but cure rates remain low for certain blood cancer types, along with considerable long-term effects from traditional therapies. For the benefit of children, a better understanding of tumor biology and further progress in drug development and treatment are needed.
Grant Details
The LLSC’s Pediatric Blood Cancer Research Innovation Grant is a two-year grant designed to provide funding to research that will lead to a significant change in the understanding, diagnosis, or treatment of pediatric blood cancers.
The LLSC will provide funding up to a maximum of $100,000 per year for two years (up to a maximum total of $200,000 for the two years)
Applicants are welcome to contact us to determine their eligibility to apply.
How to apply
The application process will occur in two phases.
Phase I - Submission and consideration of a Letter of Intent (LOI).
Phase II - Invitation to submit a Full Application.
The applicant must register with the LLSC Research Portal, Proposal Central, in order to apply. Both the LOI and the Full Application must be submitted electronically to the LLSC Research Portal.
Funds for competitive applications will be awarded on the basis of scientific merit, using a priority rating system.
- Call for Proposals - September 12, 2024
- Letter of Intent (LOI) due - November 6, 2024, 4:00 pm (ET)
- Notification of Full Application Invite - November 2024
- Full application deadline - February 5, 2025, 4:00 pm ET
- Review Panel Meeting - April 2025
- Notification of Awards - Summer 2025
- Award Start Date - Fall 2025
Submitting a Letter of Intent is mandatory for all applicants.